D. Jeffrey Keyser, Director at Lantern Pharma Inc. (LTRN), bought 48,544 shares at $2.06 ($100K) on 2026-05-12, disclosed to the SEC on 2026-05-14.
Open-market purchase of $100k LTRN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.